Robert J. Perez - 23 May 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Howard Horn, Attorney-in-Fact
Issuer symbol
VIR
Transactions as of
23 May 2022
Net transactions value
$0
Form type
4
Filing time
25 May 2022, 17:53:48 UTC
Previous filing
25 May 2021
Next filing
14 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +6,405 +190% $0.000000 9,779 23 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +12,810 $0.000000 12,810 23 May 2022 Common Stock 12,810 $24.14 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.